Patent · US Active

4,6-diaminopyrimidines useful as kinase inhibitors

US8748606B2 · kind B2 · utility

7Cited by
11References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2012
Grant dateJun 10, 2014
Priority date
Expiry dateNov 9, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/582
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides 4,6-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.